FLC Capital Advisors »

Takeda Pharmaceutical shares owned by FLC Capital Advisors

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by FLC Capital Advisors from 13F filings

Historical chart of FLC Capital Advisors investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by FLC Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by FLC Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $167k 11k 14.64
2025-06-30 $176k 11k 15.46

More positions owned by FLC Capital Advisors

Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Spdr Series Trust Portfolio Ln Tsr (SPTL)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Msci Emrg Chn (EMXC)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Series Trust Bloomberg Intl T (BWX)
Dimensional Etf Trust Us Small Cap Etf (DFAS)

View all positions for FLC Capital Advisors

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Morgan Stanley
UBS Group
Goldman Sachs Group
FMR
Brandes Investment Partners
Renaissance Technologies
BlackRock
Toronto-Dominion Bank
Arrowstreet Capital, Limited Partnership
Millennium Management
First Trust Advisors
Northern Trust
Qube Research & Technologies
Citadel Advisors

View all funds holding Takeda Pharmaceutical